BiotechTube
Home/Pipeline/Natural Product Collaboration

Natural Product Collaboration

Not Specified

Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Pre-clinical
Status
Active
Company
Crystec Pharma

About Crystec Pharma

Crystec Pharma is a private, platform technology company leveraging its proprietary mSAS® (modified Supercritical Anti-Solvent) process to engineer drug particles with high precision. The technology aims to solve key pharmaceutical challenges like poor solubility and stability, offering services to partners for drug reformulation and development. While likely pre-revenue or in early revenue from collaborations, its value proposition centers on de-risking and accelerating drug development programs for clients through its AI-enabled screening tool and scalable manufacturing platform.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved